LCID vs NRIX · rev $1.35B vs rev $54.5M
Lucid Group Inc (LCID) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Lucid Group Inc (LCID) is a auto manufacturers company listed on NASDAQ. It is led by Peter Rawlinson.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported LCID revenue for 2025-12-31 was $1.35B. Net income was -$2.70B. Revenue was up 67.6% from 2024-12-31 to 2025-12-31. LCID currently screens at market cap $2.04B.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
LCID currently screens at market cap $2.04B. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the LCID and NRIX stock pages for the full models.
Not investment advice.